Company news
Renalytix Plc (LSE:RENX) news
Renalytix Plc news releases on 6ix. Latest, Mar 31, 2022: $30.0 million financing package
Press releases — page 4
$30.0 million financing package
March 31, 2022
Timothy Scannell appointed to the Board
March 30, 2022
Enrollment Milestone for KidneyIntelX
March 29, 2022
Renalytix Launches myIntelX
March 9, 2022
Presentation of new clinical data for KidneyIntelX
February 24, 2022
RENX to Present at Cowen 42nd Annual Conference
February 22, 2022
Conference attendance
January 27, 2022
Positive Study Results Published for KidneyIntelX
January 11, 2022
Partnership with Singing River for KidneyIntelX
January 10, 2022
Appointment of Jean M. Casner as CHRO
January 7, 2022
RENX to present at 40th JP Morgan Healthcare Conf.
January 5, 2022
Joint program with American Diabetes Association
January 4, 2022
Renalytix Reports Financial Results for Q1 of FY22
December 7, 2021
Notice of Q1 FY22 Results
December 2, 2021
Publication of Annual Report 2021 & Notice of AGM
November 19, 2021
Renalytix Convenes Panel at VA Healthcare Summit
November 10, 2021
Partnership with St. Joseph's Health
November 9, 2021
Issue of shares and Total Voting Rights
November 1, 2021
Renalytix Reports Full Year Fiscal 2021 Results
October 21, 2021
Renalytix to Report Q4 and Full Year Results
October 8, 2021
VA Health System roll-out & VP sales appointment
October 7, 2021
Update on MCIT Rule
September 14, 2021
Issue of shares and TVR
September 13, 2021
Presentation at 2021 Wells Fargo Healthcare Conf.
September 3, 2021
Appointment of Daniel J. Levangie to Board
August 31, 2021
Peer reviewed publication
August 26, 2021
Director/PDMR Dealing
August 6, 2021
Appointment of Ann Berman to Board of Directors
July 28, 2021
VP of Global Quality and Regulatory Appointment
July 22, 2021
Exercise of Options and TVR
July 19, 2021
Exercise of options, PDMR transaction and TVR
July 7, 2021
New data for KidneyIntelX
June 28, 2021
Exercise of options
June 25, 2021
Change of name
June 24, 2021
Director/PDMR Shareholding - Replacement
June 22, 2021
Financial Results for Third Quarter of FY 2021
June 15, 2021
Notice of Results & Change of Auditor
June 10, 2021
Key new hires to drive commercialization strategy
June 7, 2021
Utility Study
June 3, 2021
Partnership
May 19, 2021
10-year US Government contract award
April 22, 2021
Positive clinical outcome data for KidneyIntelX
April 20, 2021
Exclusive option agreement
April 14, 2021
Clinical Utility Study
April 8, 2021
Clinical findings published in Diabetologia
April 6, 2021
Update on Finalization of MCIT Rule
March 15, 2021
Issue of shares, PDMR Dealing and TVR
March 4, 2021
Financial Results for Second Quarter of FY 2021
March 2, 2021
University of Utah Kidney Health Partnership
February 24, 2021
ASN & Renalytix to Co-Host Capital Markets Day
February 4, 2021